Anticancer Drugs 2016 10;27(9):908-13
a'Sandro Pitigliani' Medical Oncology Unit bRadiology Unit cNuclear Medicine Unit, Hospital of Prato, Prato dSarcoma Unit, Department of Cancer Medicine, Istituto Nazionale Tumori, Milan eRadiotherapy Unit fNuclear Medicine Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST-IRCCS), Meldola gAnatomic Pathology Unit, General Hospital of Treviso, Treviso, Italy.